Epidermal Growth Factor and Membrane Trafficking: Egf Receptor Activation of Endocytosis Requires Rab5a by Barbieri, M. Alejandro et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2000/10/539/12 $5.00
The Journal of Cell Biology, Volume 151, Number 3, October 30, 2000 539–550
http://www.jcb.org/cgi/content/full/151/3/539 539
 
Epidermal Growth Factor and Membrane Trafficking: 
EGF Receptor Activation of Endocytosis Requires Rab5a
 
M. Alejandro Barbieri,* Richard L. Roberts,* Aysel Gumusboga,* Hilary Highﬁeld,* 
 
Carmen Alvarez-Dominguez,
 
‡
 
 Alan Wells,
 
§
 
 and Philip D. Stahl*
 
*Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110;
 
‡
 
Centro de Biologia Molecular SEVERO OCHOA, 28033 Madrid, Spain; 
 
§
 
Department of Pathology, University of Pittsburgh, 
Pittsburgh, Pennsylvania 15261
 
Abstract. 
 
Activated epidermal growth factor receptors
recruit various intracellular proteins leading to signal
generation and endocytic trafﬁcking. Although acti-
vated receptors are rapidly internalized into the en-
docytic compartment and subsequently degraded in ly-
sosomes, the linkage between signaling and endocytosis
is not well understood. Here we show that EGF stim-
 
ulation of NR6 cells induces a speciﬁc, rapid and
transient activation of Rab5a. EGF also enhanced
translocation of the Rab5 effector, early endosomal au-
toantigen 1 (EEA1), from cytosol to membrane. The
activation of endocytosis, ﬂuid phase and receptor me-
diated, by EGF was enhanced by Rab5a expression, but
 
not by Rab5b, Rab5c, or Rab5a truncated at the NH
 
2
 
and/or COOH terminus. Dominant negative Rab5a
(Rab5:N34) blocked EGF-stimulated receptor-medi-
ated and ﬂuid-phase endocytosis. EGF activation of
Rab5a function was dependent on tyrosine residues
 
in the COOH-terminal domain of the EGF recep-
 
tor (EGFR). Removal of the entire COOH termi-
nus by truncation (c’973 and c’991) abrogated ligand-
 
induced Rab5a activation of endocytosis. A “kinase-dead”
EGFR failed to stimulate Rab5a function. However,
another EGF receptor mutant (c’1000), with the kinase
domain intact and a single autophosphorylation site ef-
fectively signaled Rab5 activation. These results indi-
cate that EGFR and Rab5a are linked via a cascade
that results in the activation of Rab5a and that appears
essential for internalization. The results point to an in-
terdependent relationship between receptor activation,
signal generation and endocytosis.
Key words: signal transduction • endocytosis • Rab5
• endosome • fusion
 
Introduction
 
Receptor signaling and receptor trafficking appear to be
tightly linked cellular events. Both receptors with intrinsic
 
tyrosine kinase activity (RPTK)
 
1
 
 (Sorkin, 1998) and G
protein–coupled receptors (Bunemann and Hosey, 1999)
have been shown to be internalized upon addition of
ligand to cells. Receptor signaling cascades are initiated
immediately after receptor ligation, which is followed by
the internalization of receptor-ligand complexes. Internal-
ization of signal transducing receptors appears to be medi-
ated exclusively via coated vesicles, possibly via types of
coated pits (Warren et al., 1997; Vickery and von Zastrow,
1999). Signaling cascades associated with receptors have
been shown to be actively involved in the assembly of
coated vesicles (Wang and Moran, 1996; Lohi et al., 1998;
Wilde et al., 1999), suggesting that the activated receptor
orchestrates its own internalization. After internalization,
activated RPTK receptors continue to signal via their re-
spective activated kinase domains (Haugh et al., 1999;
Rizzo et al., 1999). Many questions about the physiologic
rationale for the coupling of receptor signaling and recep-
tor internalization have remained unanswered (Gruen-
berg and Maxfield, 1995). Early workers suggested that in-
ternalization of receptor–ligand complexes provides a way
to attenuate signaling responses by removing receptors
from the cell surface (Wells et al., 1990). More recently,
work from many labs has suggested that the nature of the
signaling response to a ligand may be influenced by the
quality of the internalization event. It may be possible for
receptors to partner with one or more siblings in a given
family of receptors (e.g., the Erb family) that in turn may
affect their internalization rates and intracellular itinerary
(Olayioye et al., 1998; Waterman et al., 1999). Moreover,
the endosome may provide a staging platform for the as-
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sembly of signaling complexes, which are then putatively
transported to different cellular destinations (Sorkin et al.,
1993; Grimes et al., 1996).
The EGF receptor (EGFR) represents the prototype
and best studied example of a RPTK receptor (Wells,
1999). EGFR is actively internalized upon addition of
EGF. Activation of the receptor stimulates a cascade of
activities, all of which appear to be mediated by the kinase
associated with the receptor (Wells, 1999). A key down-
stream event after receptor ligation is the activation of the
extracellular-regulated kinase/microtubule-activated pro-
tein (ERK/MAP) kinase pathway (Moghal and Sternberg,
1999; Rizzo et al., 1999). Activation of the EGFR kinase
leads to autophosphorylation of the receptor protein, and
the recruitment of Eps15 (Torrisi et al., 1999) and the
adapter AP-2 (Vieira et al., 1996; Sorkin, 1998; Sorkina et
al., 1999). A second activity revealed by recent studies in-
dicates that activated EGF receptors stimulate SRC ki-
nase, which in turn mediates phosphorylation of clathrin
(Wilde et al., 1999). Clearly, these events prepare the path
for rapid internalization and targeting of the receptor. The
linkage between signaling and trafficking is partially met
by the activation of proximal activities such as recruitment
to the coated pit and activation of clathrin assembly pro-
cesses (Vieira et al., 1996). However, little is known about
the activation of more distal events (i.e., that require
Rab5, a rate limiting GTPase required for endocytosis;
Gruenberg and Maxfield, 1995), and the linkage between
proximal and distal events. In this paper, we explore the
role of Rab5 and its isoforms (Lutcke et al., 1995; Alvarez-
Dominguez and Stahl, 1998; Chiariello et al., 1999) in two
pathways known to be activated by EGFR. These include
(a) activation of fluid phase endocytosis and (b) receptor-
mediated endocytosis (i.e., EGF stimulated internalization
of EGF–EGFR complexes). Our results indicate that both
events are selectively stimulated by the Rab5a isoform,
and inhibited by the dominant negative mutant of Rab5a
(Rab5a:N34)
 
.
 
Materials and Methods
 
Cell Culture and Quiescence Protocol
 
NR6 mouse fibroblasts transfected with human EGFR wild type and mu-
tants (Chen et al., 1994) were cultured in Corning tissue culture dishes in a
5% CO
 
2
 
 environment. All cell culture reagents were obtained from Life
Technologies. The growth medium consisted of minimum essential me-
dium (
 
a
 
-MEM), 26 mM sodium bicarbonate with 5% fetal bovine serum,
2 mM 
 
L
 
-glutamine, 1 mM sodium pyruvate, 0.1 mM 
 
a
 
-MEM nonessential
amino acids, and the antibiotics penicillin, streptomycin, and G418 (350
 
m
 
g/ml). Cells were growth arrested at subconfluence using restricted se-
rum conditions without G418 (
 
a
 
-MEM, 26 mM sodium bicarbonate with
3% dialyzed fetal bovine serum, 2 mM 
 
L
 
-glutamine, 1 mM sodium pyru-
vate, 0.1 mM nonessential amino acids, and the antibiotics penicillin/strep-
tomycin) for 16 h before experiments. Experiments were carried out in
binding buffer [
 
a
 
-MEM, 13 mM HEPES, pH 7.4 at 37
 
8
 
C, with 0.3% dia-
lyzed fetal bovine serum, 2 mM 
 
L
 
-glutamine, including bovine serum albu-
min (1 mg/ml), penicillin, and streptomycin], in an air environment.
 
Construction of Recombinant Sindbis Viruses
 
cDNAs of Rab5a, Rab5b, Rab5c were subcloned into the unique XbaI re-
striction site of the Sindbis vector Toto1000:32J (Li and Stahl, 1993). The
cDNA of GFP-Rab5a, GFP-Rab5b, and GFP-Rab5c was subcloned as de-
scribed by Roberts et al. (1999). The plasmid was then linearized by XhoI
digestion and used as a template for in vitro transcription with SP6 RNA
polymerase. The resulting RNA transcripts were used for transfection of
confluent BHK-21 cell monolayers using a Lipofectin-mediated proce-
dure (Life Technologies). Cells were maintained at 37
 
8
 
C, and the media
containing released viruses were harvested 40 h after transfection. Virus
titers were generally between 10
 
8
 
 and 10
 
9
 
 plaque-forming units per millili-
ter. Virus stocks were aliquoted and kept frozen at 
 
2
 
80
 
8
 
C before use.
 
Uptake Assays
 
NR6 monolayers were mock infected or infected with the vector or re-
combinant viruses as described (Li et al., 1995). At 6 h after infection or as
otherwise indicated, cells were washed twice with serum-free 
 
a
 
-MEM,
and HRP uptake was initiated by adding HRP (5 mg/ml) in 
 
a
 
-MEM (1 ml)
containing 0.2% bovine serum albumin and 13 mM Hepes, pH 6.8 at 37
 
8
 
C,
either in the presence or absence of EGF. Cell lysates were assayed for
HRP activity (Li et al., 1995).
 
Receptor Internalization Studies
 
Mouse EGF (Life Technologies) was iodinated with 
 
125
 
I (NEN Life Sci-
ence Products) using IODO-BEADS (Pierce Chemical Co.), according to
the manufacturer’s protocol. The specific activities of labeled ligands were
typically 150,000 cpm/ng (600 Ci/mmol). Quiescent NR6 cells expressing
different Rab constructs (Rab5, Rab7, Rab11, and mutants) were washed
in binding buffer, incubated at 4
 
8
 
C for 3 h with 100 pM 
 
125
 
I-EGF, and
warmed-up for different periods of time as indicated in each figure. Sur-
face-bound and internalized ligand were discriminated essentially as de-
scribed (Sorkin et al., 1991). In brief, unbound ligand was removed by
washing the monolayer six times with ice-cold buffer containing (mM): 20
Hepes, 130 NaCl, 5 KCl, 0.5 MgCl
 
2
 
, 1 CaCl
 
2
 
, 1 mg/ml polyvinylpyrolidone,
pH 7.4. Surface-bound ligand was then collected in ice-cold acid strip
buffer (50 mM glycine-HCl, 100 mM NaCl, 1 mg/ml polyvinylpyrolidone,
pH 3.0) for 2 min, and internalized ligand was released in 1 N NaOH over-
night at room temperature. Nonspecific binding (
 
,
 
2%) was assessed in
the presence of 200 nM unlabeled human EGF (Sigma-Aldrich) and sub-
tracted from the total. Transferrin uptake was carried out essentially as re-
ported earlier (D’Souza-Schorey et al., 1995).
 
Receptor Downregulation Assay
 
NR6 cells transfected with virus alone or with virus encoding Rab5 con-
structs were incubated for various times with 100 nM of EGF at 37
 
8
 
C, and
then rinsed with cold medium. Surface EGF was then removed by mild
acid/salt treatment as described above. Remaining cell surface binding
sites were then quantified by incubating the cells with 100 pM 
 
125
 
I-EGF at
4
 
8
 
C for 2 h. Alternatively, NR6 cells were metabolically labeled overnight
with 
 
35
 
S-methionine at 37
 
8
 
C in methionine-free medium containing 1% di-
alyzed calf serum. The cells were then transfected with virus alone or virus
encoding different Rab5 constructs for 6 h. The cells were then washed
three times and incubated in binding medium with or without 100 nM
EGF for the indicated chase times. At the end of the chase, the cells were
washed, lysed, and the EGFR was immunoprecipitated with anti–EGFR
antibodies (Ab-5 monoclonal antibody; Oncogene Research Products).
The immunoprecipitates were resuspended in sample buffer and sepa-
rated in 7.5% SDS-PAGE. The gels were then soaked in enhancing solu-
tion, dried, and exposed to film (Eastman Kodak Co.) at 
 
2
 
80
 
8
 
C. The rela-
tive amount of EGFR protein was determined by counting the excised
bands in a 
 
g
 
 counter.
 
Whole Cell Lysates and Western Blotting
 
Serum-starved NR6 cells were incubated with 100 mM EGF for the indi-
cated times at 37
 
8
 
C. Cell monolayers were washed with phosphate-buff-
ered saline containing 1 mM sodium orthovanadate, 5 mM 
 
b
 
-glycerophos-
phate, and lysed in ice-cold lysis buffer (1% Nonidet P-40, 10% glycerol,
50 mM Hepes, 100 NaCl, 1 mM sodium orthovanadate, 5 mM 
 
b
 
-glycero-
phosphate, 5 mM EDTA, 1 mM Na F, 1 mM PMSF, 2 
 
m
 
g/ml pepstatin A,
2 
 
m
 
g/ml leupeptin, and 2 
 
m
 
g/ml aprotinin, pH 7.2). The lysate was vortexed
and clarified by centrifugation at 16,000 
 
g 
 
for 15 min at 4
 
8
 
C. Protein con-
centration in lysates was determined using the detergent-compatible pro-
tein assay (Bio-Rad Laboratories). Cell lysates (5 
 
m
 
l) were analyzed by
SDS-PAGE, and the proteins were transferred to a nitrocellulose mem-
brane using a semi-dry transfer apparatus (Bio-Rad Laboratories). The
membranes were probed with different antibodies as indicated in each fig-
ure legend and the immunoblots were developed using the ECL reagents
from Amersham Pharmacia Biotech. 
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Confocal Microscopy
 
NR6 cells, grown on glass coverslips and inverted on glass slides (made
into a narrow flow cell by strips of vacuum grease; Heuser et al., 1993)
were examined by confocal microscopy either in the presence or absence
of 100 nM EGF in 
 
a
 
-MEM containing 0.1% bovine serum albumin and 25
mM Hepes, pH 7.2. Time-lapsed confocal microscopy was carried out on a
confocal microscope (MRC1024; Bio-Rad Laboratories) using a 63
 
3
 
, 1.4
numerical aperture bright-field objective and fluorescein filter sets.
 
Determination the Nucleotide Status of Rab5
 
To determine the ratio of GTP to GDP bound to Rab5a (GTP/GDP ratio),
confluent (5 
 
3
 
 10
 
5
 
 cells/dish) NIH3T3 cells expressing Rab5a were incu-
bated in alpha-MEM phosphate-free medium for 3 h with 300 
 
m
 
Ci of 
 
32
 
Pi
(200 
 
m
 
Ci/mmol; Amersham Pharmacia Biotech.). After incubation, the
cells were stimulated with 100 nM EGF for 15 min. The cells were then ly-
sed as described (Barbieri et al., 1998b), and Rab5 was immunoprecipi-
tated using a 4F11 monoclonal antibody bound to the protein A-sepharose
(Amersham Pharmacia Biotech.) for 10 min at 4
 
8
 
C in lysis buffer (Barbieri
et al., 1998b). The beads were washed three times with wash buffer [20 mM
Tris-Cl, 0.1% Nonidet P-40, 500 mM NaCl, 5 mM MgCl
 
2
 
,1 mM EGTA, 1
mM DTT, 1 mg/ml bovine serum albumin, 50 mM 
 
b
 
-glycerophosphate, 10
mM NaF, 1 mM Na
 
3
 
VO
 
4
 
, 1 mM PMSF, 2 
 
m
 
g/ml aprotinin (PMSF), and 2
 
m
 
g/ml leupeptin] and three times with wash buffer containing 0.001% SDS.
The bound nucleotides were then eluted in 12 
 
m
 
l of buffer (10 mM EDTA,
1 mM DTT, 0.1% SDS, 5 mM GDP, 5 mM GTP) for 3 min at 85
 
8
 
C. All the
manipulations, from lysis of the sample to elution of the nucleotides bound
to Rab5, were carried out at 4
 
8
 
C within 40 min. 4-
 
m
 
l samples were then
spotted onto polyethyleneimine-cellulose TLC (Merck) plates, which were
developed for 60 min in 0.75 M phosphate, pH 3.4. The samples were dried
and placed in autoradiography cassettes. For visualization of the 
 
32
 
P-
labeled GTP and GDP, films were exposed at 
 
2
 
80
 
8
 
C for 24–36 h. A phos-
phoimager was used to determine the GTP/GDP ratio.
 
Results
 
EGF stimulates endocytosis and the formation of large
GFP-Rab5a positive endosomes. The initial stages of en-
docytosis are mediated by a series of fusion events that
have been extensively studied both in vivo and in vitro.
The GTPase Rab5 has been shown to be a key regulatory
factor for these vesicle docking and fusion events (Bar-
bieri et al., 1998a; McBride et al., 1999). Previous reports
have shown that expression of Rab5a:L79, a GTPase-
defective mutant, activates endocytosis and induces the
formation of enlarged endosomes (Stenmark et al., 1994;
Roberts et al., 1999). Moderately enlarged endosomes also
occur in cells over-expressing Rab5a:wild type (Rab5a),
but much smaller in size than in cells expressing Rab5a:
L79. To analyze the effect of EGF receptor stimulation on
Rab5 function, cells were transiently transfected with
Sindbis virus encoding GFP-Rab5a, GFP-Rab5a:N34, and
GFP-Rab5a:L79. The transfected cells were then incu-
bated in the presence or absence of EGF as described in
Materials and Methods. After incubation, the cells were
fixed and studied by confocal microscopy. Fig. 1, A and D,
shows that the addition of EGF to cells expressing GFP-
Rab5a results in a dramatic increase of the size of GFP-
Rab5a–positive endosomes. The endosomes are similar in
appearance to those observed when the Rab5a:L79 con-
struct is expressed (Fig. 1 B). However, in cells expressing
either GFP-Rab5a:L79 or GFP-Rab5a:N34, the addition
Figure 1. EGF induces the for-
mation of enlarged Rab5-posi-
tive endosomes. Cells express-
ing GFP-Rab5a (A and D),
GFP-Rab5a:L79 (B and E), and
GFP-Rab5a:N34 (C and F) were
grown on coverslips and then
were incubated in the presence
or absence of 100 nM EGF for
15 min at 378C. After stimula-
tion, the cells were fixed with
2% paraformaldehyde, and then
visualized by confocal micros-
copy. Cells expressing GFP-
Rab5a (G–I) were incubated in
the presence of 200 nM Texas
red–EGF for 10 min at 378C,
fixed, and then visualized by
confocal microscopy. Internal-
ized Texas red–EGF (I) accu-
mulated in the enlarged endo-
somes in cells expressing Rab5a
(G). The yellow color indicates
areas of colocalization of inter-
nalized Texas red–EGF and
GFP-Rab5a (I). Optical sections
viewed are 0.4 mM. Bars, 1 mM. 
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of EGF did not result in any morphological change [Fig. 1,
B and E (Rab5a:L79), and C and F (Rab5a:N34)]. These
results suggested that activation of the EGF receptor has a
direct effect on Rab5a function. Moreover, the enlarged
endosomal structures observed upon EGF receptor stimu-
lation by EGF are accessible to EGF itself. We used Texas
red (Tx)–EGF to monitor the internalization of EGF in
cells expressing GFP-Rab5a. Tx-EGF was prebound to
cells at 4
 
8
 
C. The cells were then incubated at 37
 
8
 
C for 5
min to induce internalization. In cells expressing GFP-
Rab5a (Fig. 1 G), the internalized Tx-EGF was found in
an enlarged vesicular compartment (H), with characteris-
tics quite similar to those observed in cells expressing
Rab5a:L79 (B). In contrast, cells expressing GFP-Rab5a:
N34 internalized substantially less Tx-EGF. Confocal mi-
croscopy of the internalized Tx-EGF in the latter showed
a diffuse punctuate staining pattern (data not shown). The
merged image in Fig. 1, G and H, shows that the Tx-EGF
and GFP-Rab5a overlap substantially, if not completely
(Fig. 1 I). After treatment of GFP-Rab5a–expressing cells
with EGF, docking and fusion of two or more green endo-
somes were observed in all the preparations examined
(data not shown; Barbieri et al., 1998a). Taken together,
these data suggest that stimulation of EGFR regulates
Rab5 function, which, in turn, affects the endocytic rate
and fusion between endosomes.
 
EGF Enhances GTP Loading of Rab5a
 
 
 
and Membrane 
Recruitment of the Rab5a Interacting Protein, 
Early Endosomal Autoantigen 1
 
To further examine EGF activation of Rab5a, serum-
starved cells were labeled with 
 
32
 
Pi to analyze the nu-
cleotide status of Rab5a. Cells were then exposed to
EGF (100 ng/ml) for 10 min. The cells were lysed and
Rab5a was immunoprecipitated with monoclonal anti–
Rab5 (4F11) antibody. 
 
32
 
P-guanine nucleotides, released
from the Rab5a immunoprecipitates, were analyzed by TLC.
The results in Fig. 2 A show that the GTP bound form of
Rab5a is rapidly accumulated after exposure of the cells to
EGF. Consistent with previous data, 
 
z
 
90% of the Rab5a
was in the GDP bound form in unstimulated cells. In stim-
ulated cells, 
 
z
 
80% of the Rab5a was found in the GTP
bound form. Also shown in Fig. 2 A is the effect of EGF in
cells expressing two truncated constructs of the EGF re-
ceptor, c’973, which is known not to be internalized, and
c’1000, which is internalized. Activation of Rab5a in cells
expressing these constructs is consistent with the conclu-
sion that a fully active EGF receptor is required for Rab5a
recruitment/activation. Representative data for one of
these experiments, where 
 
32
 
P-labeled guanine nucleotides
were released from the immunoprecipitated Rab5a and
separated by TLC, is shown in Fig. 2 A (bottom). A sec-
ond measure of the effect of EGF receptor activation on
Figure 2. Membrane-cytosol re-
distribution of Rab proteins in
the presence of EGF. (A) Cells
expressing EGFR:WT (wild
type) and mutants labeled with
32Pi, were transfected with GFP-
Rab5a. Cells were incubated
with 100 nM EGF for 15 min
and the nucleotide status of
Rab5 was analyzed as indicated
in Materials and Methods
(mean  6 SD, n 5 3.) (Bottom)
The results from a typical ex-
periment. (B) Cells expressing
EGFR:WT were transfected with
GFP-Rab5a. After transfection,
the cells were incubated in the
presence 100 nM EGF for 15
min and the membrane-cytosol
distribution of EEA1 proteins
was analyzed by Western blot.
The experiment was repeated
three times with similar results. 
Barbieri et al. 
 
Epidermal Growth Factor and Endocytosis Requires Rab5a
 
543
 
accelerated endocytosis is the status of early endosomal
autoantigen 1 (EEA1), a cytosolic Rab5 interacting pro-
tein believed to be involved in the membrane recruitment
of Rab5. Cells were incubated with EGF, and at 5 min the
cells were lysed and membrane and cytosol fractions were
prepared. The fractions were separated by SDS-PAGE
and EEA1 was detected by Western blotting. As shown in
Fig. 2 B, addition of EGF to NR6 cells, caused a rapid (5
min) shift of EEA1 from cytosol to the membrane.
 
EGF Stimulation of Fluid Phase Endocytosis 
Is Rab5a-dependent
 
Another measure of the linkage between activation of the
EGF receptor and Rab5a is fluid phase endocytosis (Fig. 3
A). EGF is well known to enhance the rate of fluid phase
endocytosis. However, we found that EGF-stimulated
fluid phase endocytosis was specifically increased by the
expression of Rab5a. Both the initial rate of uptake and
the accumulation of HRP over 15 min was substantially
enhanced by the presence of GFP-Rab5a. Dominant nega-
tive Rab5a (GFP-Rab5a:N34) blocked both control en-
docytosis and EGF-induced fluid phase endocytosis. West-
ern blots of cell lysates (Fig. 3, A–C) indicated that the
constructs used were expressed to approximately the same
level. As shown in Fig. 3 B, expression of GFP-Rab7 or
GFP-Rab11 had no effect on the endocytic response to
EGF either when expressed as wild-type proteins or as
dominant negatives (GFP-Rab7:T22N or GFP-Rab11:
MB1). Shown for comparison in Fig. 3 B are the pro-
nounced effects of Rab5a, both dominant negative Rab5a:
N34 and Rab5a, on EGF-stimulated fluid phase endocyto-
sis. To further explore the role of Rab5a in EGF activation
of endocytosis, a series of Rab5a mutants were employed.
In Fig. 3 C, cells transfected with COOH-terminal (Rab5a:
 
D
 
C4) and NH
 
2
 
-terminal (Rab5a:
 
D
 
N19) truncation mutants
of Rab5a, as well as Rab5a:N34, were stimulated with
EGF. As expected, Rab5a:N34 had a dramatic inhibitory
effect on the endocytosis of HRP. Both the NH
 
2
 
- and
COOH-terminal deletion mutants of Rab5a were unable
to facilitate the endocytic response to EGF. In spite of its
inability to facilitate the response to EGF, Rab5a:
 
D
 
N19
was modestly active in stimulating endocytosis in the ab-
sence of EGF, as reported earlier (Li and Stahl, 1993).
Moreover, the endocytic effect of Rab5a:
 
D
 
N19 was abol-
ished by the double mutant, Rab5a:
 
D
 
N19/N34. Rab5a:
 
D
 
C4, on the other hand, was both inactive in endocytosis
and unable to support the endocytic effect of EGF. The
double mutant Rab5a:
 
D
 
C4/N34 was also inactive. As ex-
Figure 3. HRP-stimulated EGF-dependent endocytosis requires the small GTPase
Rab5. (A) Cells expressing EGFR:WT were either transfected with virus alone (con-
trol: s, d), virus encoding Rab5 (m, n), or virus encoding Rab5:N34 (h, j). After
transient transfection, the amount of HRP internalized at 378C for the indicated times
was quantified in the presence (n, s, h) or absence (d, m, j) of EGF. This experi-
ment was repeated at least three times with similar results. (B) Cells expressing
EGFR were transfected with virus encoding Rab5, Rab5:N34, Rab11, Rab11:mB1,
Rab7, or Rab7:N22. After transfection, the internalization of HRP (378C for 10 min)
was quantified in the presence or absence of 100 nM EGF. Values are mean 6 SD, n 5
3. (C) Cells expressing EGFR:WT were either transfected with virus alone, virus en-
coding Rab5, virus encoding Rab5:N34, virus encoding Rab5:N34/DN19, virus encod-
ing Rab5:DN19, virus encoding Rab5:DC4, or virus encoding Rab5:DC4/N34. After
transient transfection, the amount of HRP internalized at 378C for 15 min was quanti-
fied in the presence or absence of 100 nM EGF. Values are mean 6 SD, n 5 3.The Journal of Cell Biology, Volume 151, 2000 544
pected, the inhibitory effect of Rab5a:N34 was abolished
by COOH-terminal truncation. These results show that
the NH2- and COOH-terminal domains as well the GTP-
binding domain are required for optimal function of
Rab5a in EGF-stimulated HRP endocytosis.
Effects of EGF on Receptor-mediated Endocytosis 
Are Rab5-dependent
As shown above for fluid phase endocytosis, Rab5a is re-
quired for accelerated receptor-mediated endocytosis of
125I-EGF. After EGF binding, the uptake of 125I-EGF in
cells expressing GFP-Rab5a was substantially accelerated
(Fig. 4 A). Endocytosis of 125I-EGF was unaffected by ex-
pression of either GFP-Rab7 or GFP-Rab11 at 15 min of
uptake. On the other hand, expression of Rab5a:N34
blocked 125I-EGF uptake (Fig. 4 B). Expression of the
Rab11 and Rab7 dominant-negative mutants did not sig-
nificantly interfere with EGF internalization at 15 min at
378C (data not shown). At later time points, under condi-
tions where internalized 125I-EGF was transported to the
lysosomal compartment (data not shown), 125I-EGF accu-
mulation was still strongly blocked by Rab5a:N34, but also
partially inhibited by Rab7:N22. Similar to the require-
ment for an intact Rab5a molecule for the EGF-stimu-
lated fluid-phase endocytosis, accelerated internalization
of  125I-EGF also required intact Rab5a (Fig. 4 B). The ac-
celerated internalization of 125I-EGF was not supported by
Rab5a:DN19 nor by Rab5a:DC4. To examine more di-
rectly the effect of Rab5:N34 on the internalization and
degradation of the EGF receptor, two additional experi-
ments were carried out. In Fig. 4 C (left), the effect of
Rab5:N34 expression on the loss of 125I-EGF binding in re-
sponse to added EGF was quantified. Addition of EGF to
cells is known to trigger internalization and degradation of
the receptor. In Fig. 4 C, cells infected with the control vi-
rus or virus encoding Rab5a, rapidly lost cell surface 125I-
EGF binding within z2 h after addition of EGF. When
cells expressing Rab5a:N34 were examined with the same
protocol, a binding capacity substantially delayed in the
loss of EGF was recorded. At 2 h after EGF addition,
there was only a 25% decrease in EGF binding capacity
Figure 4. Endocytosis of EGF
requires the small GTPase
Rab5. (A) Cells expressing
EGFR:WT were either trans-
fected with virus alone (s), vi-
rus encoding Rab5a (d), virus
encoding Rab7 (m), or virus en-
coding Rab11 (j). After tran-
sient transfection, the amount of
125I-EGF internalized at 378C
for the indicated times was
quantified. This experiment was
repeated at least four times, and
the results were highly repro-
ducible. (B) Cells expressing
EGFR were transiently trans-
fected with either virus alone,
virus encoding Rab5, Rab5:N34,
Rab5:N34/DN19, Rab5:DN19,
Rab5:DC4, or Rab5:DC4N34.
After transfection, uptake of
125I-EGF was carried out at 378C
for 10 min (mean 6 SD, n 5 3).
(C) Cells transfected with virus
alone or virus encoding Rab5:
WT or Rab5:N34 were treated
with EGF for different times.
Surface EGFR was analyzed by
125I -EGF binding as described
in Materials and Methods. This
experiment was repeated at
least three times, and the results
were reproducible. (D) 35S-
methionine–labeled NR6 cells
transfected with virus alone, or
virus encoding Rab5:WT or
Rab5:N34, were treated with
EGF. At the indicated times, ali-
quots were removed and EGFR
was immunoprecipitated from
cell lysates with anti–human
EGFR antibody as described in
Materials and Methods.Barbieri et al. Epidermal Growth Factor and Endocytosis Requires Rab5a 545
in cells expressing Rab5a:N34, whereas cells expressing
Rab5a suffered an 80% loss in EGF binding. In Fig. 4 C
(right), cells were metabolically labeled and radiolabeled
EGF receptor was immunoprecipitated from cell lysates at
different times after the addition of EGF to the cells. Cells
infected with the control virus or virus encoding Rab5a
rapidly lost radiolabeled receptor (see Fig. 4 C, inset) over
the course of z2 h, whereas cells expressing Rab5a:N34
demonstrated only small losses in immunoprecipitable
EGF receptor.
Truncated Forms of the EGF Receptor that Are 
Signaling-restricted Do Not Activate Endocytosis, 
Even in the Presence of Rab5a
To identify the structural components of the EGF recep-
tor that are responsible for enhanced endocytosis after
EFG stimulation, several experiments were carried out
with a series of EGF-receptor truncation mutants, as de-
scribed in Fig. 5. Stable cell lines expressing the wild-type
EGFR and mutant EGF receptors were transiently trans-
fected with Sindbis virus encoding GFP-Rab5a. As shown
in Fig. 5 A, the expression of Rab5a in cells expressing the
wild-type EGFR caused a further increase in the fluid
phase uptake of HRP after the addition of EGF (Fig. 5 A)
and in the internalization of 125I-EGF (B). However, in
cells expressing either EGFR:c’973 or EGFR:c’991, the
expression of Rab5a did not have any effect on the uptake
of HRP or 125I-EGF. Interestingly, in cells expressing
EGFR c’1000, the endocytic effect of Rab5a expression
was restored; i.e., cells expressing EGFR:c’1000 continue
to accelerate fluid phase endocytosis and EGF internaliza-
tion in response to Rab5a expression (Fig. 5, A and B). As
a control, we examined the effect of transferrin on fluid-
phase endocytosis. Transferrin binds to the transferrin re-
ceptor and is internalized via clathrin-coated vesicles. As
shown in Fig. 5 C, Rab5a increased (and Rab5a:N34 de-
creased) HRP endocytosis to the same extent in the pres-
ence or absence of transferrin. Rab5a and Rab5a:N34 also
increased and decreased, respectively, the uptake of 125I
transferrin, as shown earlier (Barbieri et al., 1998a) (Fig. 5
D). The addition of transferrin did not induce any change
in the cytosol/membrane ratio of Rab5a (data not shown).
Furthermore, no enlarged Rab5-positive endosomes were
observed in cells stimulated with transferrin (data not
shown). The effects of EGF in cells expressing the EGFR
truncation mutants are confirmed at the morphological
level in Fig. 6, where it is shown that incubation of cells ex-
pressing the wild-type EGFR and EGFR:c’1000, with
EGF results in an increase in the size of GFP-Rab5a–posi-
tive endosomes. In contrast, the size of GFP-Rab5a–
tagged endosomes remains unaffected by EGF stimulation
in cells coexpressing GFP-Rab5a and EGFR:c’973 or
EGFR:c’991 constructs (Fig. 6). These results indicate that
residues in the tail of the EGFR are required for the regu-
lation of Rab5 function, which, in turn, affect fluid-phase
as well as EGF receptor–mediated endocytosis.
Stimulation of Endocytosis by EGF 
Is Rab5 Isoform-specific
To determine the specificity of the activation of Rab5 by
EGFR, we explored the possible role of the other two
Rab5 isoforms, Rab5b and Rab5c. Three isoforms of Rab5
Figure 5. Endocytosis of HRP
and EGF require an intact cyto-
plasmic domain of the EGFR.
Cells expressing either EGFR:
WT, EGFR:c’973, EGFR:c’991,
or EGFR:c’1000 were trans-
fected with virus alone or virus
encoding Rab5. After transient
transfection, the amount of
HRP (A) or 125I-EGF (B) inter-
nalized at 378C was quantified
as described in Materials and
Methods (mean 6 SD, n 5 4).
(C and D) Cells were trans-
fected with virus alone, or virus
encoding Rab5, or Rab5:N34
and the internalization of either
HRP (C) or 125I-Tf (D) was car-
ried out for 10 min at 378C in the
presence or absence of 6 mg/ml
transferrin. Mean 6 SD, n 5 3.The Journal of Cell Biology, Volume 151, 2000 546
have been described (Lutcke et al., 1995; Chiariello et al.,
1999). Rab5a is the most studied and best characterized
isoform. All of the isoforms have been shown to be active
in endocytosis after transient expression (Lutcke et al.,
1995). To determine whether the activation of the other
isoforms (Rab5b and Rab5c) were also regulated by EGF,
cells expressing Rab5b and Rab5c were incubated with
EGF and stimulated endocytosis was recorded. As shown
in Fig. 7 A, expression of all three Rab5 isoforms in-
creased the uptake of HRP under nonstimulated condi-
tions. Surprisingly, whereas Rab5a was a potent enhancer
of HRP endocytosis in cells stimulated by EGF, Rab5b
and Rab5c were inactive. Furthermore, EGF stimulation
did not change the cytosolic/membrane distribution of
Rab5b and Rab5c (data not shown). To complement the
studies on fluid-phase endocytosis, we next investigated
the uptake of 125I-EGF in cells expressing Rab5a, Rab5b,
and Rab5c. In Fig. 7 B, expression of Rab5a specifically in-
creased the rate of 125I-EGF endocytosis. In contrast, the
expression of the Rab5b and Rab5c isoforms did not sub-
stantially increase the rate of the EGF endocytosis. Mor-
phological analysis show that enlarged endosomes were
only observed in EGF-stimulated cells expressing the
Rab5a isoform (Fig. 8). Fig. 8, A and D, shows the effect
of EGF in cells expressing GFP-Rab5a. Fig. 8, B and E,
shows the effects of EGF in cells expressing GFP Rab5b;
Fig. 8, C and D, shows the effects of EGF in cells express-
ing GFP-Rab5c. Fig. 8, D–F (insets), shows more clearly
the differential effects of EGF and Rab5a in producing
large endosomes. Rab5b is virtually inactive; i.e., unable to
enhance this effect of EGF. Rab5c is only modestly active.
Discussion
While many cell-surface receptors (Hopkins and Trow-
bridge, 1983; Hanover et al., 1984; Lamaze et al., 1993) are
thought to internalize and recycle constitutively; e.g.,
transferrin and low density lipoprotein receptors (Gold-
stein et al., 1985; Hopkins et al., 1985), others, such as
many tyrosine kinase growth-factor receptors and G pro-
tein–coupled receptors, are internalized only after binding
to their respective agonists. Moreover, many signal-trans-
ducing receptors, internalized by ligand addition, are de-
graded via transport to lysosomes (Beguinot et al., 1984).
A direct linkage between receptor activation and receptor
internalization was revealed by the studies of Sorkin and
colleagues (Sorkin, 1998; Sorkina et al., 1999), beginning
with the report that the EGF receptor, upon activation
with EGF, interacts with adapter complexes (Sorkin and
Carpenter, 1993). Recent work has shown that activation
of the EGF receptor leads to activation of Eps15, a sub-
strate for EGF-receptor kinase (Benmerah et al., 1995;
van Delft et al., 1997; Torrisi et al., 1999). Eps15 appears
to be an organizing molecule mediating many of the func-
tions associated with RPTK growth-factor responses in eu-
caryotic cells (Torrisi et al., 1999). G protein–linked recep-
Figure 6. Formation of en-
larged Rab5-positive endo-
somes requires an intact cyto-
plasmic domain of the EGFR.
Cells expressing either EGFR:
WT, EGFR:c’973, EGFR:c’991,
or EGFR:c’1000 were trans-
fected with virus encoding GFP-
Rab5a. After transient transfec-
tion, the cells were incubated
with EGF and the formation of
enlarged endosomes were visu-
alized by confocal microscopy as
described in Materials and
Methods. This experiment was
repeated three times and the re-
sults were highly reproducible.Barbieri et al. Epidermal Growth Factor and Endocytosis Requires Rab5a 547
tor internalization is promoted via the effects of arrestin,
which enhances clathrin-coated pit localization of this
class of receptors (Bunemann and Hosey, 1999; Premont
et al., 1999) and several reports have suggested that G pro-
tein–linked receptors need not be internalized to generate
signals (Bunemann and Hosey, 1999; Luttrell et al., 1999;
Premont et al., 1999). However, for the tyrosine kinase–
linked receptors, results to date suggest that receptor in-
ternalization and receptor signaling are linked (Sorkin,
1998; Torrisi et al., 1999).
In this paper, we explore EGF-receptor activation of the
GTPase Rab5 and the linkage between signaling and en-
docytic trafficking. Rab5 is the rate-limiting GTPase for
endocytosis (Bucci et al., 1992; Li et al., 1994; Stenmark et
al., 1994). The dominant-negative mutant of Rab5, Rab5:
N34, reduces endocytic rate and blocks in vitro endosome
fusion (Li et al., 1994). Rab5 is activated by guanine nucle-
otide exchange, a process that is coupled to Rab5 recruit-
ment from the cytosol to the membrane fraction (McBride
et al., 1999; Ullrich et al., 1994). Downstream effectors of
Rab5 include EEA1 and Syntaxin among other proteins
(Simonsen et al., 1999; McBride et al., 1999) and a direct
interaction among Rab5, EEA1, and Syntaxin (Simonsen
et al., 1999) strengthens earlier work suggesting a linkage
between RabGTPases and SNARES (soluble N-ethyl-
maleimide–sensitive factor attachment protein receptor;
Sogaard et al., 1994). Several proteins have been identified
that act as guanine nucleotide exchange factors and GTP-
ase-activating proteins for Rab5, including Rabex5
(Horiuchi et al., 1997), VPS9 (Hama et al., 1999), and tu-
berin (Xiao et al., 1997), respectively. Moreover, recent
work indicates that EEA1, a FYVE domain containing
early endosome protein, which specifically binds three
phosphorylated phosphatidylinositols, is required for the
tethering of Rab5 to the membrane (Stenmark and
Aasland, 1999). A major unanswered question is how
Rab5 is recruited and activated since it is known that mul-
tiple upstream events activate endocytosis (Li et al., 1997).
In this context, it is interesting that addition of EGF to
cells stimulated the membrane recruitment of EEA1. It is
possible that this represents an early event in Rab5 re-
cruitment and/or activation.
Using the EGF receptor as a model, we show that EGF
stimulation of receptor-mediated endocytosis and fluid-
phase endocytosis is Rab5-dependent and is coupled to
Rab5 activation. On the other hand, the dominant nega-
tive mutant of Rab5a (Rab5a:N34) blocks both processes.
At the light microscope level, we took advantage of GFP-
tagged Rab5 molecules to trace the effect of EGF on the
endocytic pathway. EGF stimulates the formation of en-
larged endosomes that can be monitored in living cells.
Multiple in vivo endosome fusion events are readily ob-
served in the EGF stimulated preparation (Roberts et al.,
1999; Barbieri, M.A., and P.D. Stahl, unpublished data).
The effect of Rab5 on enhancing EGF endocytosis was
specific. Expression of Rab7 and Rab11, as wild-type or
dominant-negative constructs, were unable to enhance the
endocytic effects of EGF. An important set of experiments
linking the EGF pathway to activation of Rab5 is found in
Fig. 2. Here, addition of EGF to serum-starved cells re-
sults in GTP loading of Rab5; green fluorescent protein
(GFP) Rab5 and endogenous Rab5 behave virtually the
same in this assay, confirming the use of the GFP con-
structs for these experiments.
The EGF receptor has served as a model for signal
transduction studies and many truncation and deletion
mutants have been characterized. As shown in Figs. 2, 5,
and 6, the effect of Rab5a on enhancing the endocytic ef-
fect depends on signal-transduction pathways elicited by
the EGF tyrosine kinase. Truncation mutants of EGFR,
which do not undergo autophosphorylation or activate
PLCg and other SH2-containing effectors, also fail to syn-
ergize with Rab5 in elevating endocytosis. Thus, a signal
transduction pathway activated by EGF tyrosine kinase
appears to mediate activation of Rab5. This pathway may
involve phosphatidylinositol 3-kinase and protein kinase B
since wortmannin and expression of dominant-negative
PKB/akt, respectively, substantially block the EGF effect
on endocytosis (data not shown).
What is the relationship of the EGF receptor to Rab5 in
the context of signal transduction? Interaction of ligands
with cell-surface EGF receptors initiates (a) the recruit-
ment of cytosolic proteins, (b) the generation of activated
effector molecules, and (c) the internalization and, pre-
Figure 7. EGFR specifically reg-
ulates Rab5a function. (A) Cells
expressing EGFR:WT were
transfected with virus alone or
virus encoding Rab5a, Rab5b, or
Rab5c, and the internalization of
HRP in the presence or absence
of 100 nM EGF was carried out
for 10 min at 378C (mean 6 SD,
n  5  3). (B) Cells expressing
EGFR:WT were transfected as
in A. After transfection, the up-
take of 125I-EGF was carried out
at 378C for 10 min as described
in Materials and Methods.
Mean  6 SD, n 5 3.The Journal of Cell Biology, Volume 151, 2000 548
sumably, the correct intracellular targeting of occupied re-
ceptors. Thus it was very interesting that expression of
dominant-negative Rab5a (Rab5a:N34) resulted in an ab-
rogation of the effect of EGF, not only on fluid-phase en-
docytosis, but also the EGF receptor–mediated endocyto-
sis. The effect of Rab5a:N34 is specific. Expression of
Rab7 and Rab11, as wild-type or dominant-negative con-
structs, were unable to enhance the early endocytic effects
of EGF. By what mechanism does Rab5:N34 block EGF
signal transduction? McLauchlan et al. (1998) have sug-
gested that Rab5 is incorporated into nascent-coated vesi-
cles. Others have failed to detect Rab5 in coated vesicles
(Fischer von Mollard et al., 1994; our unpublished obser-
vations), although the difference in results may have to
due with methodology. It is possible that the incorporation
of Rab5 or a Rab5-interacting protein into an EGF-recep-
tor/macromolecular complex at the membrane precedes
and is required for the formation of a clathrin-coated vesi-
cle. In the former case, dominant-negative Rab5a, trapped
in the GDP form, would fail to be recruited to the mem-
brane, thereby inhibiting the EGF receptor–dependent
coated vesicle assembly. In the latter scenario, Rab5a:N34
would sequester a factor that is needed for assembly of an
EGF-receptor macromolecular complex. The latter would
be consistent with the hypothesis that Rab5 may be incor-
porated into newly formed endosomes after their forma-
tion but before docking and fusion. Carter et al. (1993)
suggested some years ago that a GTPase may play an early
role in coated vesicle formation based on inhibition by
guanosine 59-[g-thio]triphosphate, a nonhydrolyzable ana-
logue of GTP, of the sequestration phase of coated vesicle
formation in vitro. As shown in Fig. 5, B and C, Rab5a and
Rab5a:N34 had robust effects on transferrin receptor in-
ternalization, which further supports the idea that the
dominant-negative Rab5a disrupts early events. A second
signaling pathway, further delineated by this study, is the
pathway that leads from EGF receptor activation to stimu-
lation of fluid-phase endocytosis. Many studies have dem-
onstrated the effect of EGF and other growth factors on
fluid-phase endocytosis. Indeed, West et al. (1989) have
attributed a portion of the fluid phase endocytic effect of
EGF to macropinocytosis. Since wortmannin and Rab5a:
N34 block EGF activation of fluid-phase endocytosis, it is
likely that EGF activates fluid-phase endocytosis by a
novel signaling pathway. Earlier work with activated Ras
(RasV12) demonstrated that activation of endocytosis via
Ras used the phosphatidylinositol 3-kinase and PKB/akt
pathways (Barbieri et al., 1998b; Li et al., 1997).
Lastly, an intriguing set of observations concerns the
specific effects of the Rab5a isoform in EGF-stimulated
endocytosis and signal transduction. The effect of EGF on
endocytosis and the selective effects of the Rab5 isoforms
can be seen clearly by light confocal microscopy. EGF
stimulates endocytosis and the formation of large endo-
somes, which are GFP-Rab5a positive. This effect is Rab5
isoform-specific and the endosomes that are formed are
Figure 8. The formation of enlarged endosomes by EGF is specific for the Rab5a isoform. Cells expressing EGFR:WT were transfected
with virus encoding GFP-Rab5a (A and D), GFP-Rab5b (B and E), or GFP-Rab5c (C and F), and the visualization of the formation of
enlarged endosomes were analyzed as described in Materials and Methods. This experiment was repeated three times and the results
were highly reproducible.Barbieri et al. Epidermal Growth Factor and Endocytosis Requires Rab5a 549
both GFP-Rab5 and Tx-EGF positive (Fig. 2). Rab5a very
strongly facilitates the formation of large endosomes after
EGF stimulation, whereas Rab5b is virtually inactive.
Rab5c is intermediate between Rab5a and Rab5b. Rab5
exists as three closely related molecules in mammalian
cells. All three isoforms are ubiquitously expressed in en-
dosomal membranes and all enhance endocytosis when
overexpressed in a variety of cells. Singer-Kruger et al.
(1994) cloned three isoforms of Rab5-like GTPases in
yeast, Ypt51p, Ypt52p Ypt55p, and demonstrated that all
play a role in endocytosis and targeting to the vacuole.
They envisioned each of these closely related Rab5 GTP-
ases playing key, possibly sequential, roles along a com-
plex pathway. Based on work suggesting a role in host
defense (Alvarez-Dominguez and Stahl, 1998) in and
phagocytosis (Alvarez-Dominguez and Stahl, 1999), we
showed that Rab5a is selectively induced in mammalian
macrophages by interferon. Chiariello et al. (1999) re-
cently showed differential phosphorylation of the Rab5
isoforms. Selective induction of the Rab5 isoforms, as
demonstrated by the recent studies using DNA microchips
to catalog gene induction by serum (Iyer et al., 1999), cou-
pled with the aforementioned effects of interferon and the
selective post-translational modification of the Rab5 GTP-
ases, highlight the point that the three Rab5 isoforms most
likely have different functions. These findings also antici-
pate the identification of alternate, perhaps parallel, en-
docytic pathways.
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